South and Central America Biopharmaceutical Contract Manufacturing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Biologics and Biosimilar), Service (Process Development, Fill and Finish Operation, Analytical and QC Studies, and Packaging), and Source (Mammalian and Microbial-Based Biologics/Non-Mammalian)

Code: TIPRE00028646 | Pages: 124 | Industry: Pharmaceuticals | Date: Apr 2022 | Type: Regional

The biopharmaceutical contract manufacturing market in South and Central America is expected to grow from US$ 564.89 million in 2021 to US$ 866.71 million by 2028; it is estimated to register a CAGR of 6.3% from 2021 to 2028.

 

The contract manufacturing organization (CMO) offers many benefits to pharmaceutical companies, including reducing investments in facilities and drug development costs, thereby improving net cash flow. Outsourcing is cheaper and enhances the efficiency of manufacturing processes. It allows pharmaceutical & biotechnology companies to redirect resources to other areas. In the past few years, the contract manufacturing industry was a niche service market offering more manufacturing capacity or specific services to pharmaceutical companies. The rise of CMOs was fueled by the rising number of drug manufacturing failures. Pharmaceutical companies undertook many manufacturing facilities to develop innovative drugs in the past. However, the demand for manufacturing outsourcing has continuously risen to reduce the risk of overcapacities. Moreover, several pharmaceutical companies are refocusing on their core capabilities, such as research and development, leading to divestments of in-house manufacturing capacities, further growing reliance on CMOS for manufacturing. Furthermore, the CMOs are vital in providing additional benefits to mitigate the risk of supply shortages by offering various sites for pharmaceutical companies with multisite supply strategies and backup capacities.

 

South and Central America Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (US$ Million)

South and Central America Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :


 

South and Central America Biopharmaceutical Contract Manufacturing Market Segmentation     

 

South and Central America Biopharmaceutical Contract Manufacturing Market – By Product

  • Biologics
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
    • Others
  • Biosimilar

 

South and Central America Biopharmaceutical Contract Manufacturing Market – By Service

  • Process Development
    • Downstream Processing
    • Upstream Processing
  • Fill and Finish Operation
  • Analytical and QC Studies
  • Packaging

South and Central America Biopharmaceutical Contract Manufacturing Market – By Source

  • Mammalian
  • Microbial-Based Biologics/ Non-Mammalian

South and Central America Biopharmaceutical Contract Manufacturing Market– By Country

  • Brazil
  • Argentina
  • The Rest of South and Central America

South and Central America Biopharmaceutical Contract Manufacturing Market-Companies Mentioned

  • AbbVie Inc.
  • Ajinomoto Co. Inc
  • Boehringer Ingelheim International GmbH
  • General Electric Company
  • Lonza
  • MERCK KGAA
  • Samsung Biologics
  • THERMO FISHER SCIENTIFIC INC

1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SCAM Biopharmaceutical Contract Manufacturing Market – By Product

1.3.2        SCAM Biopharmaceutical Contract Manufacturing Market – By Service

1.3.3        SCAM Biopharmaceutical Contract Manufacturing Market – By Source

1.3.4        SCAM Biopharmaceutical Contract Manufacturing Market – By Country

2.           SCAM Biopharmaceutical Contract Manufacturing Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SCAM Biopharmaceutical Contract Manufacturing – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        SCAM – PEST Analysis

4.3         Expert Opinion

5.           SCAM Biopharmaceuticals Contract Manufacturing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Outsourcing by Pharmaceutical Companies

5.1.2        Increasing Demand for Biologics

5.2         Market Restraints

5.2.1        Surge in Competition in Industry

5.3         Future Trends

5.3.1        Consolidation in Pharmaceutical CMO Industry

5.3.2        COVID-19 Pandemic

5.4         Impact Analysis

6.           Biopharmaceutical Contract Manufacturing Market – SCAM Analysis

6.1         SCAM Biopharmaceutical Contract Manufacturing Market Revenue Forecast and Analysis

7.           SCAM Biopharmaceuticals Contract Manufacturing Market Analysis – By Product

7.1         Overview

7.2         SCAM Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)

7.3         Biologics

7.3.1        Overview

7.3.2        Biologics: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Monoclonal Antibodies

7.3.2.1.1          Overview

7.3.2.1.2          Monoclonal Antibodies: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Recombinant Proteins

7.3.2.2.1          Overview

7.3.2.2.2          Recombinant Proteins: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3          Vaccines

7.3.2.3.1          Overview

7.3.2.3.2          Vaccines: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.4          Others

7.3.2.4.1          Overview

7.3.2.4.2          Others: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Biosimilar

7.4.1        Overview

7.4.2        Biosimilar: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.           SCAM Biopharmaceuticals Contract Manufacturing Market – By Service

8.1         Overview

8.2         SCAM Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)

8.3         Process Development

8.3.1        Overview

8.3.2        Process Development: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1          Downstream Processing

8.3.2.1.1          Overview

8.3.2.1.2          Downstream Processing: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2          Upstream Processing

8.3.2.2.1          Overview

8.3.2.2.2          Upstream Processing: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Fill and Finish Operations

8.4.1        Overview

8.4.2        Fill and Finish Operations: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Analytical and QC Studies

8.5.1        Overview

8.5.2        Analytical and QC Studies: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Packaging

8.6.1        Overview

8.6.2        Packaging: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

9.           SCAM Biopharmaceuticals Contract Manufacturing Market – By Source

9.1         Overview

9.2         SCAM Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)

9.3         Mammalian

9.3.1        Overview

9.3.2        Mammalian: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Microbial/Non-Mammalian-Based Biologics

9.4.1        Overview

9.4.2        Microbial/Non-Mammalian-Based Biologics: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10.        SCAM Biopharmaceutical Contract Manufacturing Market – Country Analysis

10.1      SCAM: Biopharmaceutical Contract Manufacturing Market

10.1.1     Overview

10.1.3     SCAM: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

10.1.3.1       Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1.1       Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1.2       Brazil: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.3.1.2.1     Brazil: Biologics Market, 2019-2028 (USD Million)

10.1.3.1.3       Brazil: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.3.1.3.1     Brazil: Process Development Market, 2019-2028 (USD Million)

10.1.3.1.4       Brazil: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.3.2       Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2.1       Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2.2       Argentina: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.3.2.2.1     Argentina: Biologics Market, 2019-2028 (USD Million)

10.1.3.2.3       Argentina: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.3.2.3.1     Argentina: Process Development Market, 2019-2028 (USD Million)

10.1.3.2.4       Argentina: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.3.3       Rest of SCAM: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.3.1       Rest of SCAM: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.3.2       Rest of SCAM: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.3.3.2.1     Rest of SCAM: Biologics Market, 2019-2028 (USD Million)

10.1.3.3.3       Rest of SCAM: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.3.3.3.1     Rest of SCAM: Process Development Market, 2019-2028 (USD Million)

10.1.3.3.4       Rest of SCAM: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

11.        Biopharmaceutical Contract Manufacturing Market – Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Boehringer Ingelheim International GmbH

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      THERMO FISHER SCIENTIFIC INC.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      General Electric Company

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      MERCK KGAA

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Lonza

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Samsung Biologics

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      AbbVie Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Ajinomoto Co. Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             SCAM Biopharmaceutical Contract Manufacturing Market –Revenue and Forecast to 2028 (US$ Million)

Table 2.             Brazil Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 3.             Brazil Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 4.             Brazil Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 5.             Brazil Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 6.             Brazil Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 7.             Argentina Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 8.             Argentina Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 9.             Argentina Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 10.          Argentina Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 11.          Argentina Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of SCAM Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of SCAM Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 14.          Rest of SCAM Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 15.          Rest of SCAM Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 16.          Rest of SCAM Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 17.          Organic Developments Done By Companies

Table 18.          Inorganic Developments Done By Companies

Table 19.          Glossary of Terms, SCAM Biopharmaceutical Contract Manufacturing Market

 


LIST OF FIGURES

Figure 1.           SCAM Biopharmaceutical Contract Manufacturing Market Segmentation

Figure 2.           SCAM Biopharmaceutical Contract Manufacturing Segmentation, By Country

Figure 3.           SCAM Biopharmaceutical Contract Manufacturing Market Overview

Figure 4.           Biologics Segment Held Largest Share Of Product In SCAM Biopharmaceutical Contract Manufacturing Market

Figure 5.           Brazil Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           SCAM PEST Analysis

Figure 7.           SCAM Biopharmaceutical Contract Manufacturing Market Impact Analysis of Drivers and Restraints

Figure 8.           SCAM Biopharmaceutical Contract Manufacturing Market – Revenue Forecast and Analysis – 2020 - 2028

Figure 9.           SCAM Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)

Figure 10.        Biologics: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Monoclonal Antibodies: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Recombinant Proteins: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Vaccines: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Others: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Biosimilar: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        SCAM Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)

Figure 17.        Process Development: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Downstream Processing: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Upstream Processing: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Fill and Finish Operations: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Analytical and QC Studies: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Packaging: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        SCAM Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)

Figure 24.        Mammalian: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Microbial/Non-Mammalian-Based Biologics: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        SCAM: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)

Figure 27.        SCAM: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

Figure 28.        Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Rest of SCAM: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

  1. AbbVie Inc.
  2. Ajinomoto Co. Inc
  3. Boehringer Ingelheim International GmbH
  4. General Electric Company
  5. Lonza
  6. MERCK KGAA
  7. Samsung Biologics
  8. THERMO FISHER SCIENTIFIC INC
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000